Hemoxygenase-1 Promotes Head and Neck Cancer Cell Viability
- Autores
- Mascaró, Marilina; Alonso, Exequiel G.; Schweitzer, Karen; Rabassa, Martín Enrique; Carballido, Jessica Andrea; Ibarra, Agustina; Alonso, Eliana N.; Bermúdez, Vicente; Fernández Chavez, Lucía; Coló, Georgina P.; Ferronato, María Julia; Pichel, Pamela; Recio, Sergio; Clemente, Valentina; Fermento, María Eugenia; Facchinetti, María Marta; Curino, Alejandro C.
- Año de publicación
- 2022
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Head and neck squamous cell carcinoma (HNSCC) is a remarkably heterogeneous disease with around 50% mortality, a fact that has prompted researchers to try new approaches to improve patient survival. Hemoxygenase-1 (HO-1) is the rate-limiting step for heme degradation into carbon monoxide, free iron and biliverdin. We have previously reported that HO-1 protein is upregulated in human HNSCC samples and that it is localized in the cytoplasmic and nuclear compartments; additionally, we have demonstrated that HO-1 nuclear localization is associated with malignant progression. In this work, by using pharmacological and genetic experimental approaches, we begin to elucidate the mechanisms through which HO-1 plays a role in HNSCC. We found that high HO-1 mRNA was associated with decreased patient survival in early stages of HNSCC. In vitro experiments have shown that full-length HO-1 localizes in the cytoplasm, and that, depending on its enzymatic activity, it increases cell viability and promotes cell cycle progression. Instead, HO-1 does not alter migration capacity. Furthermore, we show that C-terminal truncated HO-1 localizes into the nucleus, increases cell viability and promotes cell cycle progression. In conclusion, we herein demonstrate that HO-1 displays protumor activities in HNSCC that depend, at least in part, on the nuclear localization of HO-1.
Centro de Investigaciones Inmunológicas Básicas y Aplicadas - Materia
-
Medicina
Biología
hemoxygenase-1
nucleus
cancer
head and neck - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- http://creativecommons.org/licenses/by/4.0/
- Repositorio
- Institución
- Universidad Nacional de La Plata
- OAI Identificador
- oai:sedici.unlp.edu.ar:10915/155707
Ver los metadatos del registro completo
id |
SEDICI_d7c7531d27d54eb6756257ab4dfabf8e |
---|---|
oai_identifier_str |
oai:sedici.unlp.edu.ar:10915/155707 |
network_acronym_str |
SEDICI |
repository_id_str |
1329 |
network_name_str |
SEDICI (UNLP) |
spelling |
Hemoxygenase-1 Promotes Head and Neck Cancer Cell ViabilityMascaró, MarilinaAlonso, Exequiel G.Schweitzer, KarenRabassa, Martín EnriqueCarballido, Jessica AndreaIbarra, AgustinaAlonso, Eliana N.Bermúdez, VicenteFernández Chavez, LucíaColó, Georgina P.Ferronato, María JuliaPichel, PamelaRecio, SergioClemente, ValentinaFermento, María EugeniaFacchinetti, María MartaCurino, Alejandro C.MedicinaBiologíahemoxygenase-1nucleuscancerhead and neckHead and neck squamous cell carcinoma (HNSCC) is a remarkably heterogeneous disease with around 50% mortality, a fact that has prompted researchers to try new approaches to improve patient survival. Hemoxygenase-1 (HO-1) is the rate-limiting step for heme degradation into carbon monoxide, free iron and biliverdin. We have previously reported that HO-1 protein is upregulated in human HNSCC samples and that it is localized in the cytoplasmic and nuclear compartments; additionally, we have demonstrated that HO-1 nuclear localization is associated with malignant progression. In this work, by using pharmacological and genetic experimental approaches, we begin to elucidate the mechanisms through which HO-1 plays a role in HNSCC. We found that high HO-1 mRNA was associated with decreased patient survival in early stages of HNSCC. In vitro experiments have shown that full-length HO-1 localizes in the cytoplasm, and that, depending on its enzymatic activity, it increases cell viability and promotes cell cycle progression. Instead, HO-1 does not alter migration capacity. Furthermore, we show that C-terminal truncated HO-1 localizes into the nucleus, increases cell viability and promotes cell cycle progression. In conclusion, we herein demonstrate that HO-1 displays protumor activities in HNSCC that depend, at least in part, on the nuclear localization of HO-1.Centro de Investigaciones Inmunológicas Básicas y Aplicadas2022-10info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionArticulohttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfhttp://sedici.unlp.edu.ar/handle/10915/155707enginfo:eu-repo/semantics/altIdentifier/issn/2076-3921info:eu-repo/semantics/altIdentifier/doi/10.3390/antiox11102077info:eu-repo/semantics/openAccesshttp://creativecommons.org/licenses/by/4.0/Creative Commons Attribution 4.0 International (CC BY 4.0)reponame:SEDICI (UNLP)instname:Universidad Nacional de La Platainstacron:UNLP2025-09-29T11:40:26Zoai:sedici.unlp.edu.ar:10915/155707Institucionalhttp://sedici.unlp.edu.ar/Universidad públicaNo correspondehttp://sedici.unlp.edu.ar/oai/snrdalira@sedici.unlp.edu.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:13292025-09-29 11:40:26.913SEDICI (UNLP) - Universidad Nacional de La Platafalse |
dc.title.none.fl_str_mv |
Hemoxygenase-1 Promotes Head and Neck Cancer Cell Viability |
title |
Hemoxygenase-1 Promotes Head and Neck Cancer Cell Viability |
spellingShingle |
Hemoxygenase-1 Promotes Head and Neck Cancer Cell Viability Mascaró, Marilina Medicina Biología hemoxygenase-1 nucleus cancer head and neck |
title_short |
Hemoxygenase-1 Promotes Head and Neck Cancer Cell Viability |
title_full |
Hemoxygenase-1 Promotes Head and Neck Cancer Cell Viability |
title_fullStr |
Hemoxygenase-1 Promotes Head and Neck Cancer Cell Viability |
title_full_unstemmed |
Hemoxygenase-1 Promotes Head and Neck Cancer Cell Viability |
title_sort |
Hemoxygenase-1 Promotes Head and Neck Cancer Cell Viability |
dc.creator.none.fl_str_mv |
Mascaró, Marilina Alonso, Exequiel G. Schweitzer, Karen Rabassa, Martín Enrique Carballido, Jessica Andrea Ibarra, Agustina Alonso, Eliana N. Bermúdez, Vicente Fernández Chavez, Lucía Coló, Georgina P. Ferronato, María Julia Pichel, Pamela Recio, Sergio Clemente, Valentina Fermento, María Eugenia Facchinetti, María Marta Curino, Alejandro C. |
author |
Mascaró, Marilina |
author_facet |
Mascaró, Marilina Alonso, Exequiel G. Schweitzer, Karen Rabassa, Martín Enrique Carballido, Jessica Andrea Ibarra, Agustina Alonso, Eliana N. Bermúdez, Vicente Fernández Chavez, Lucía Coló, Georgina P. Ferronato, María Julia Pichel, Pamela Recio, Sergio Clemente, Valentina Fermento, María Eugenia Facchinetti, María Marta Curino, Alejandro C. |
author_role |
author |
author2 |
Alonso, Exequiel G. Schweitzer, Karen Rabassa, Martín Enrique Carballido, Jessica Andrea Ibarra, Agustina Alonso, Eliana N. Bermúdez, Vicente Fernández Chavez, Lucía Coló, Georgina P. Ferronato, María Julia Pichel, Pamela Recio, Sergio Clemente, Valentina Fermento, María Eugenia Facchinetti, María Marta Curino, Alejandro C. |
author2_role |
author author author author author author author author author author author author author author author author |
dc.subject.none.fl_str_mv |
Medicina Biología hemoxygenase-1 nucleus cancer head and neck |
topic |
Medicina Biología hemoxygenase-1 nucleus cancer head and neck |
dc.description.none.fl_txt_mv |
Head and neck squamous cell carcinoma (HNSCC) is a remarkably heterogeneous disease with around 50% mortality, a fact that has prompted researchers to try new approaches to improve patient survival. Hemoxygenase-1 (HO-1) is the rate-limiting step for heme degradation into carbon monoxide, free iron and biliverdin. We have previously reported that HO-1 protein is upregulated in human HNSCC samples and that it is localized in the cytoplasmic and nuclear compartments; additionally, we have demonstrated that HO-1 nuclear localization is associated with malignant progression. In this work, by using pharmacological and genetic experimental approaches, we begin to elucidate the mechanisms through which HO-1 plays a role in HNSCC. We found that high HO-1 mRNA was associated with decreased patient survival in early stages of HNSCC. In vitro experiments have shown that full-length HO-1 localizes in the cytoplasm, and that, depending on its enzymatic activity, it increases cell viability and promotes cell cycle progression. Instead, HO-1 does not alter migration capacity. Furthermore, we show that C-terminal truncated HO-1 localizes into the nucleus, increases cell viability and promotes cell cycle progression. In conclusion, we herein demonstrate that HO-1 displays protumor activities in HNSCC that depend, at least in part, on the nuclear localization of HO-1. Centro de Investigaciones Inmunológicas Básicas y Aplicadas |
description |
Head and neck squamous cell carcinoma (HNSCC) is a remarkably heterogeneous disease with around 50% mortality, a fact that has prompted researchers to try new approaches to improve patient survival. Hemoxygenase-1 (HO-1) is the rate-limiting step for heme degradation into carbon monoxide, free iron and biliverdin. We have previously reported that HO-1 protein is upregulated in human HNSCC samples and that it is localized in the cytoplasmic and nuclear compartments; additionally, we have demonstrated that HO-1 nuclear localization is associated with malignant progression. In this work, by using pharmacological and genetic experimental approaches, we begin to elucidate the mechanisms through which HO-1 plays a role in HNSCC. We found that high HO-1 mRNA was associated with decreased patient survival in early stages of HNSCC. In vitro experiments have shown that full-length HO-1 localizes in the cytoplasm, and that, depending on its enzymatic activity, it increases cell viability and promotes cell cycle progression. Instead, HO-1 does not alter migration capacity. Furthermore, we show that C-terminal truncated HO-1 localizes into the nucleus, increases cell viability and promotes cell cycle progression. In conclusion, we herein demonstrate that HO-1 displays protumor activities in HNSCC that depend, at least in part, on the nuclear localization of HO-1. |
publishDate |
2022 |
dc.date.none.fl_str_mv |
2022-10 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion Articulo http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://sedici.unlp.edu.ar/handle/10915/155707 |
url |
http://sedici.unlp.edu.ar/handle/10915/155707 |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/issn/2076-3921 info:eu-repo/semantics/altIdentifier/doi/10.3390/antiox11102077 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess http://creativecommons.org/licenses/by/4.0/ Creative Commons Attribution 4.0 International (CC BY 4.0) |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
http://creativecommons.org/licenses/by/4.0/ Creative Commons Attribution 4.0 International (CC BY 4.0) |
dc.format.none.fl_str_mv |
application/pdf |
dc.source.none.fl_str_mv |
reponame:SEDICI (UNLP) instname:Universidad Nacional de La Plata instacron:UNLP |
reponame_str |
SEDICI (UNLP) |
collection |
SEDICI (UNLP) |
instname_str |
Universidad Nacional de La Plata |
instacron_str |
UNLP |
institution |
UNLP |
repository.name.fl_str_mv |
SEDICI (UNLP) - Universidad Nacional de La Plata |
repository.mail.fl_str_mv |
alira@sedici.unlp.edu.ar |
_version_ |
1844616277259190272 |
score |
13.070432 |